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ABSTRACT Late in the HIV-1 replication cycle, the viral structural protein Gag is tar-
geted to virus assembly sites at the plasma membrane of infected cells. The capsid
(CA) domain of Gag plays a critical role in the formation of the hexameric Gag lat-
tice in the immature virion, and, during particle release, CA is cleaved from the Gag
precursor by the viral protease and forms the conical core of the mature virion. A
highly conserved Pro-Pro-Ile-Pro (PPIP) motif (CA residues 122 to 125) [PPIP(122–
125)] in a loop connecting CA helices 6 and 7 resides at a 3-fold axis formed by
neighboring hexamers in the immature Gag lattice. In this study, we characterized
the role of this PPIP(122–125) loop in HIV-1 assembly and maturation. While muta-
tions P123A and P125A were relatively well tolerated, mutation of P122 and I124
signiﬁcantly impaired virus release, caused Gag processing defects, and abolished in-
fectivity. X-ray crystallography indicated that the P122A and I124A mutations induce
subtle changes in the structure of the mature CA lattice which were permissive for
in vitro assembly of CA tubes. Transmission electron microscopy and cryo-electron
tomography demonstrated that the P122A and I124A mutations induce severe struc-
tural defects in the immature Gag lattice and abrogate conical core formation. Prop-
agation of the P122A and I124A mutants in T-cell lines led to the selection of com-
pensatory mutations within CA. Our ﬁndings demonstrate that the CA PPIP(122–125)
loop comprises a structural element critical for the formation of the immature Gag
lattice.
IMPORTANCE Capsid (CA) plays multiple roles in the HIV-1 replication cycle. CA-CA
domain interactions are responsible for multimerization of the Gag polyprotein at vi-
rus assembly sites, and in the mature virion, CA monomers assemble into a conical
core that encapsidates the viral RNA genome. Multiple CA regions that contribute to
the assembly and release of HIV-1 particles have been mapped and investigated.
Here, we identiﬁed and characterized a Pro-rich loop in CA that is important for the
formation of the immature Gag lattice. Changes in this region disrupt viral produc-
tion and abrogate the formation of infectious, mature virions. Propagation of the
mutants in culture led to the selection of second-site compensatory mutations
within CA. These results expand our knowledge of the assembly and maturation
steps in the viral replication cycle and may be relevant for development of antiviral
drugs targeting CA.
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HIV-1 particles assemble predominantly at the plasma membrane (PM) of infectedcells. Assembly is driven by the main viral structural polyprotein, Gag, which
consists of four domains, namely, matrix (MA), capsid (CA), nucleocapsid (NC), and p6,
and of two short spacer peptides, SP1 and SP2 (1–3). The mechanism and pathways
that direct Gag molecules to the site of assembly are not fully understood. It has been
shown that a patch of basic amino acids near the N terminus of the MA domain and a
myristic acid moiety attached to the N-terminal Gly of MA mediate Gag targeting and
binding to the PM (4, 5). After membrane binding, Gag molecules multimerize to form
a hexameric lattice on the inner leaﬂet of the PM, leading to the assembly and release
of immature virions. Particle release is driven by direct interactions between the p6
domain of Gag and the cellular endosomal sorting complex required for transport
(ESCRT) machinery (6, 7).
The immature Gag lattice, both before and after particle release, is hexameric in its
organization, with gaps in the lattice that accommodate the strain of curvature (8).
During or shortly after release of the immature particle, the viral protease (PR) cleaves
the Gag polyprotein into four mature Gag proteins—MA, CA, NC, and p6—and SP1 and
SP2. PR-mediated Gag cleavage results in extensive structural rearrangements of the
particle interior. The most signiﬁcant rearrangement is the formation of a cone-shaped
core, the shell of which is composed predominantly of CA hexamers and 12 pentamers
that close off the ends of the capsid (9). The structural rearrangements that occur
during virus maturation lead to the formation of the mature, infectious virion. Because
the two copies of the single-stranded viral genomic RNA are packaged into the core,
along with the enzymes reverse transcriptase (RT) and integrase (IN), HIV-1 capsids
provide a suitable environment for reverse transcription early after entry into the host
cell. Thus, capsid formation is an essential step in the generation of an infectious virion.
The mechanism of conical core formation is still under investigation. Reports from
several groups have supported an assembly-disassembly model in which CA monomers
released by PR-mediated Gag processing reassemble to form the capsid core (10, 11).
In contrast, other models invoke a nondiffusional transition of the cleaved CA layer
without full disassembly of the hexameric Gag lattice (12, 13) or a combination of the
two mechanisms for the core maturation pathway (14).
In addition to their role in capsid assembly, CA-CA contacts are also indispensable
for the assembly of the immature Gag lattice. The CA domain of Gag consists of
N-terminal and C-terminal subdomains—referred to as the CA-NTD and CA-CTD, re-
spectively—connected by a short, ﬂexible linker (Fig. 1A). The CA-NTD (amino acids 1
to 145) is composed of an N-terminal -hairpin and seven -helices and a loop
(residues 85 to 93) that binds the cellular protein cyclophilin A (CypA). The CA-CTD
(residues150 to 231) consists of the major homology region (MHR) and four -helixes
(15). Extensive mutational analyses have identiﬁed a number of CA residues that are
critical for the assembly of the immature particle and the mature capsid (3). For
example, using a library of HIV-1 mutants bearing single amino acid substitutions in CA,
it was observed that most mutations in CA disrupt virion assembly (16). Key residues are
located in several regions, including helices 4, 5, and 6 of the CA-NTD; helix 9 of the
CA-CTD; and the part of the CA-CTD that includes the MHR as well as helices 10 and 11
(17). Interestingly, deletion of the CA-NTD results in only moderate impairment of the
formation of virus-like particles (VLPs), pointing to a major role for CA-CTD in virion
assembly. However, CA-NTD-deleted Gag forms VLPs with a wide size distribution,
indicating that the CA-NTD is involved in determining particle morphology (18).
Numerous structural studies have provided insights into the folding and conforma-
tion of CA in both the immature Gag lattice and the mature conical capsid (19, 20).
More recently, Briggs and colleagues used cryo-electron tomography (cryo-ET) to solve
the structure of the CA domain in the immature particle and to deﬁne more precisely
the roles of individual CA domains in the formation of the immature Gag lattice (Fig. 1B)
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(21). Each CA-NTD forms multiple contacts with CA-NTDs from the same or neighboring
hexamers. Multiple contacts between CA-CTDs also maintain the integrity of the
immature Gag lattice, and MHR residues interact within a hexamer. Residues within
helix 9, in particular, two hydrophobic amino acids, W184 and M185, form interhexa-
meric contacts across a CA-CA dimer interface. The C terminus of CA-CTD and the
N-terminal eight residues of SP1 form a six-helix bundle in the immature Gag lattice (22,
23). The CA-CTD, including a ﬂexible hinge formed by a Val-Gly-Gly motif (residues 221
to 223), and the six-helix bundle together form an assembly unit that plays a central
role in stabilizing the immature Gag lattice (22). Although the tertiary structure of the
CA monomer is highly conserved, the arrangements of the two CA domains in the
immature Gag shell differ signiﬁcantly between retroviruses (21).
The CA arrangement in the mature core has been established based on analysis of
in vitro-assembled hexameric wild-type (WT) and mutant lattices by X-ray crystallogra-
phy and cryo-electron microscopy (24–26). Most recently, the structure of the HIV-1
capsid derived from intact virions has been examined by using cryo-ET (Fig. 1C) (27).
Comparisons of the orientations of CA in the immature and mature hexameric lattices
revealed the presence of large-scale CA domain rotations and rearrangements during
the maturation process (13, 20, 21). The integrity of one mature hexamer is supported
by CA-NTD–CA-NTD and CA-NTD–CA-CTD contacts between adjacent CA monomers
and by CA-NTD–CA-CTD intrasubunit contacts. In contrast to the immature Gag lattice,
interhexameric contacts in the mature lattice are formed exclusively by the CA-CTD
(26). Subtle changes in CA structure, including movement of CA-NTD relative to CA-CTD
and rotations around CA-CTD at the 2-fold and 3-fold interfaces of CA hexamers,
together with the presence of CA pentamers, allow formation of the variably curved
mature core (27).
In this study, we determined the role in HIV-1 assembly of a highly-conserved,
Pro-rich sequence, Pro-Pro-Ile-Pro (PPIP), spanning CA residues 122 to 125 [PPIP(122–
125)], in a short loop connecting helices 6 and 7 (H6-H7) (Fig. 1A). These loops surround
the trimer interface between neighboring hexamers in the immature Gag lattice
(Fig. 1B), while this region is exposed in the mature core (Fig. 1C). It has been reported
that mutation of residue P122 or residue I124 drastically decreases the production and
infectivity of HIV-1 particles (16, 28–30); however, the basis for these defects has not
been investigated. To analyze the contribution of this loop to assembly of HIV-1
FIG 1 Location of the PPIP(122–125) motif in the HIV-1 CA monomer, immature Gag lattice, and mature
capsid. (A) HIV-1 CA is composed of N-terminal and C-terminal domains (CA-NTD and CA-CTD, respectively)
connected by a ﬂexible linker. The loop that binds the cellular protein CypA is indicated (CypA loop; arrow).
The PPIP motif (red) is located between helices 6 (green) and 7 (yellow) in the CA-NTD (PDB ID: 5MCX [27]).
(B) The CA domain is arranged in a hexameric fashion in the immature Gag lattice (in the central hexamer
CA-NTDs in orange and CA-CTDs in cyan; neighboring hexamers in gray) (PDB ID: 4USN [21]). The PPIP
motifs (red) of neighboring hexamers meet in the 3-fold interhexamer interface (triangles). Sixfold sym-
metry axes are indicated by hexagons. (C) A mature hexameric lattice in the intact virion (in the central
hexamer, CA-NTDs in orange, CA-CTDs in cyan, neighboring hexamers in gray). Conformational shifts
during maturation move the PPIP motif (red) away from the interhexamer interface in the immature Gag
lattice to a more central position in the mature CA lattice (PDB ID: 5MCX [27]). Sixfold symmetry axes are
indicated by hexagons.
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particles, we substituted alanine at each position in the PPIP motif and characterized
the mutant viruses by a combination of virological, biochemical, and structural ap-
proaches. Substitutions at two positions, P122 and I124, resulted in impaired release of
noninfectious particles containing a defective immature Gag lattice. Propagation of the
P122 and I124 mutants in T-cell line cultures led to the generation of revertant viruses
containing substitutions at several positions within the CA-NTD. These compensatory
mutations restored particle assembly and infectivity. Our results demonstrate that the
PPIP(122–125) motif plays a key role in assembly of the Gag lattice of the immature
virion and in subsequent particle maturation.
RESULTS
Mutations in the PPIP(122–125) motif cause defects in HIV-1 particle assembly
and maturation. To characterize the role of the PPIP motif spanning HIV-1 CA residues
122 to 125, we introduced Ala mutations into each position of this motif in the pNL4-3
full-length infectious molecular clone and analyzed the resulting effects on HIV-1
particle production, Gag processing efﬁciency, infectivity, replication, and maturation.
To probe the role of the PPIP(122–125) motif in virus particle production, HeLa cells
were transfected in parallel with WT and mutant molecular clones and the relative
levels of virus release efﬁciency were calculated based on the amount of radiolabeled
viral proteins in cell and virion lysates. We found that while mutation P123A did not
affect virus production, mutations P122A, I124A, and P125A reduced virus particle
production to 40%, 25%, and 60% of WT levels, respectively (Fig. 2A and B). The virus
release defects exhibited by the P122A and I124A mutants were associated with
impaired Gag processing, as measured by the ratio of cell-associated CA to the total
amount of Pr55Gag and CA in cell lysates (Fig. 2C). To determine the levels of
unprocessed Gag in virions, we collected viral particles from transfected cells and
measured the ratio of Pr55Gag to the total amount of Gag (Pr55Gag plus CA) in
particles by western blotting. The loading volumes were adjusted to account for the
fact that the P122A and I124A mutants release less virus than the WT. The levels of
Pr55Gag were about three times higher in the two mutants than in the WT virions
(Fig. 2D). The efﬁciency of the last step in Gag processing—release of CA from
CA-SP1—was measured in radiolabeled viruses produced from transfected cells
(Fig. 2E). We observed that CA-SP1 cleavage was around four times less efﬁcient in
P122A and I124 particles than in the WT particles (Fig. 2E, lanes 1, 5, and 9 and the
leftmost three bars on the graph). These data demonstrate that P122A and I124A
mutants exhibit Gag processing defects not only in producer cells but also in released
virions.
To evaluate whether the defects in virus particle production are linked to dysregu-
lation of PR-mediated Gag processing, we examined virus release efﬁciency in the
context of PR-negative (PR) molecular clones. Consistent with the results of virus
release assays performed with PR mutants, production of immature particles was
impaired by the P122A and I124A mutations (Fig. 2F). These data suggest that defects
in virus particle production by P122A and I124A viruses are not caused by aberrant Gag
processing.
To analyze the effects of the PPIP mutations on virus replication kinetics, we
transfected highly permissive MT-4 (Fig. 3A) and less-permessive Jurkat (Fig. 3B) T-cell
lines with WT or mutant molecular clones and monitored virus replication kinetics by
RT assay. We observed that the P123A and P125A viruses were replication competent
in MT-4 and Jurkat cells. In contrast, and consistent with their defects in virus assembly
and release, the P122A and I124A mutants replicated with a signiﬁcant delay relative to
the WT in MT-4 cells and were not able to replicate in Jurkat cells (Fig. 3A and B).
To examine the effects of these mutations on particle infectivity, HeLa cells were
transfected with WT and mutant molecular clones, and virus-containing supernatants
were analyzed for infectivity of speciﬁc particles in the TZM-bl indicator cell line.
Relative to WT viruses, the P123A and P125A mutants showed 70% and 20% infectivity,
respectively, whereas P122A and I124A viruses were noninfectious (Fig. 3C).
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FIG 2 P122A and I124A mutations impair virus particle production and Gag processing. HeLa cells were transfected with WT and
PPIP mutant proviral clones. At 24 h posttransfection, the cells were metabolically labeled with [35S]Met/Cys. Viral particles were
collected by ultracentrifugation. Cell lysates were immunoprecipitated with anti-HIV immunoglobulin (HIV-Ig). Viral proteins were
separated by SDS-PAGE and quantiﬁed by phosphorimager analysis. (A) A representative gel. (B) Relative virus release efﬁciency
was calculated as [virus-associated CA]/[total (cell plus virus) Gag  CA], with the WT value set at 100; error bars indicate standard
deviations (SD); n 3 independent experiments. (C) Gag processing efﬁciency in cell lysates was calculated as CA/(CA Pr55Gag).
Error bars indicate SD; n  3 independent experiments. (D) The level of unprocessed Pr55Gag in virions collected from 293T cells
was assessed by western blotting and calculated as Pr55Gag/(Pr55Gag  CA). Sample loading was adjusted to reﬂect the
decreased particle production of the P122A and I124A mutants (a representative gel is shown on the left; quantitation indicated
on the right). Error bars  SD; n  3 independent experiments. (E) Percentages of CA-SP1 calculated as CA-SP1/(CA-SP1 CA).
293T cells transfected with WT and mutant clones were incubated in the presence of dimethyl sulfoxide (DMSO) or 100 nM
maturation inhibitors (BVM or the 7m or 7r analogs) and were metabolically labeled in [35S]Met/Cys. Radiolabeled virions were
collected and viral proteins separated by SDS-PAGE. WT protein bands were exposed to a phosphorimager screen for 1 day;
(Continued on next page)
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We next examined the morphology of mutant particles by thin-section transmission
electron microscopy (TEM) and cryo-ET. The electron micrographs demonstrated that
P123A and P125A mutant particles were morphologically similar to the WT particles
(data not shown). In contrast, P122A and I124A viral particles lacked the characteristic
conical core observed with WT HIV-1 virions (Fig. 3D, upper panels). The P122A and
I124A mutants also showed an accumulation of Gag patches at the PM of virus-
producing cells, suggesting a structural role for these residues early in the assembly
process. As similar defects in virion morphology were observed for the two mutants, we
performed cryo-ET analysis only for the I124A particles (Fig. 3D, lower panels). We
veriﬁed that I124A virions lacked the conical core seen in WT particles and also lacked
any other higher-order structure made of the same (mature) lattice; we infer that these
particles represent maturation-defective virions at various stages of Gag processing.
Some virions contained a poorly ordered Gag-like layer lining the envelope/MA layer,
while others contained a density distributed throughout the particle; at least part of
that density is likely to have been derived from unassembled CA. Overall, these data
demonstrate that mutations of P122 and I124 in the highly conserved PPIP(122–125)
motif have similar phenotypes and that the motif plays a critical role in HIV-1 particle
assembly, maturation, and infectivity.
Protease-deﬁcient P122A and I124A virions have a morphologically abnormal
Gag lattice. To further deﬁne the role of the PPIP loop in virus assembly, we charac-
terized PR derivatives of the P122A and I124A molecular clones. TEM analysis of those
virus particles revealed signiﬁcant gaps or discontinuities in the Gag-like lattice for both
mutants (I124A, Fig. 4A; P122A, data not shown).
To further characterize the defects in the structure of the immature Gag lattice
caused by the P122A and I124A mutations, protease-deﬁcient WT and mutant particles
were visualized by cryo-ET (Fig. 4B). Analysis of these data revealed broader size
distributions for the P122A PR and I124A PR particles than for the WT PR particles,
and the size range peaked at a smaller diameter (Fig. 4C). Moreover, Gag was distrib-
uted more sparsely and in discontinuous patches along the viral envelope in these
mutants (Fig. 4B and D). To discern the local structure of this region, subtomogram
averaging was performed. For WT PR particles, the honeycomb pattern characteristic
of the immature Gag lattice was clearly seen in the top-down view (Fig. 4E, left panel),
and the trilaminar nature of the cross-sectional view (8, 31) was also well deﬁned
(Fig. 4E, middle and right panels). In contrast, the subtomogram average data deter-
mined for the P122A PR particles showed no evidence of the WT immature Gag lattice,
and the CA layer was thinner and nonstriated in the cross-sectional view. The I124A PR
particles were of essentially the same morphotype (Fig. 4E).
To determine whether mutations in the PPIP(122–125) motif of the CA-NTD affect
the arrangement of downstream domains in Gag in the assembled immature lattice, we
used maturation inhibitors (MIs) to probe the formation of the six-helix bundle that
spans the junction between the CA-CTD and SP1. The ﬁrst-in-class MI bevirimat (BVM)
and BVM analogs inhibit the ﬁnal cleavage step in the Gag processing cascade—the
separation of CA from CA-SP1—thereby preventing the formation of mature, infectious
particles (32–34). Recent studies suggest that BVM binds at the center of the CA-SP1
bundle and stabilizes its structure, thereby impeding the access of PR to the cleavage
site (22, 23). We thus examined whether BVM and two potent BVM analogs (7m and 7r
[34]) are able to block CA-SP1 processing of the P122A and I124A mutants. Indeed, we
observed that BVM and the two BVM analogs signiﬁcantly inhibited P122A and I124A
CA-SP1 processing, albeit not to the same level as observed with the WT (Fig 2E).
Because the six-helix CA-SP1 bundle is the target of MI activity, these data suggest that
FIG 2 Legend (Continued)
mutant viral samples were exposed for 4 to 5 days. Error bars indicate SD; n  3 independent experiments. (F) HeLa cells were
transfected with PR molecular clones. Virus release efﬁciency was calculated as virion Pr55Gag/total (cell plus virus) Pr55Gag.
Error bars indicate SD; n  3 independent experiments.
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FIG 3 P122A and I124A mutants exhibit defects in virus replication kinetics, particle infectivity, and virion morphology. (A and B) MT-4 (A) or
Jurkat (B) cells were transfected with the indicated viral clones. Aliquots of supernatants were collected every other day, and RT activity was
measured. (C) TZM-bl cells were incubated with HeLa-derived viral stocks in the presence of DEAE-dextran. After 2 to 3 h, the medium was
replaced, and at 48 h postinfection, luciferase activity was analyzed and normalized based on the levels of virus-associated RT. Error bars indicate
SD; n  3 independent experiments. (D) (Upper panels) HeLa cells were transfected with WT, P122A, or I124 molecular clones. At 24 h
posttransfection, the medium was removed, and the cells were ﬁxed with 2% glutaraldehyde–0.1 M sodium cacodylate buffer and analyzed by
TEM. Arrows indicate thick-walled, patchy Gag layers along the PM of virus-producing cells. (Lower panels) Cryo-ET analysis of WT and I124A
virions. HeLa cells were transfected with the indicated viral clones. At 48 h posttransfection, the supernatants were ﬁltered, viral particles were
pelleted by ultracentrifugation, resuspended in 1 Tris-buffered saline, ﬁxed in 3% to 4% glutaraldehyde, and imaged by cryo-ET. Shown are
central slices through I124A virions that have a disordered Gag layer (black arrowhead) or are at later stages of maturation, with the protein
density, presumably representing processed Gag, distributed throughout the interior of the particles (white arrowhead). No I124A virions
containing conical, WT-like cores were observed. Scale bars, 100 nm.
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bundle formation is not blocked by the P122A and I124A mutations, despite their
marked impact on particle assembly.
P122A and I124A subtly affect formation of the CA hexagonal lattice. As
demonstrated above, the P122A and I124A mutants are unable to produce virions
containing mature cone-shaped cores, thereby impeding investigation of the role of
the motif in assembling the mature CA lattice in the context of virus particles. To
address the effect of the PPIP mutations on the formation of the mature CA hexamer,
FIG 4 In PR-deﬁcient virions, the P122A and I124A mutations cause defects in the Gag lattice. HeLa cells were transfected with WT or
I124A HIV-1 PR clones. At 48 h posttransfection, the supernatants were ﬁltered and viral particles were collected by ultracentrifugation.
The pelleted virions were resuspended with 2% glutaraldehyde–0.1 M sodium cacodylate buffer and then concentrated by ultracentrif-
ugation. (A) TEM analysis revealed discontinuities (black arrows) in the Gag lattices of I124A virions compared to the WT virions. Scale bars,
100 nm. (B to D) Cryo-ET analysis of PR derivatives of the two mutants, a WT control, and a revertant. HeLa cells were transfected with
the indicated clones. At 48 h posttransfection, the supernatants were ﬁltered and released virions were pelleted by ultracentrifugation
followed by ﬁxation in 3% to 4% glutaraldehyde and visualized by cryo-ET. P122A and I124A particles exhibited broader size distributions
that peaked at a smaller radius than those of the WT or the revertant (C). The Gag layers of the P122A and I124A mutants are seen to
be distributed sparsely and discontinuously along the viral envelope compared to the WT or the T58S/T107I/P122A revertant (examples
delineated in yellow) (B). (D) Gag coverage was estimated for 87, 92, 84, and 35 virions for WT, P122A, I124A, and T58S/T107I/P122A
samples, respectively. Error bars indicate SD. Scale bar, 100 nm. (E) Subtomogram averaging of data from the immature Gag lattice
demonstrated that the P122A and I124A mutations disrupted the organization of the Gag lattice, whereas the T58S/T107I/P122A revertant
regained WT-like Gag lattice organization.
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full-length CA proteins bearing P122A or I124A mutations were crystallized. The
structures were solved in the P6 space group with one molecule/asymmetric unit (see
Table S1 in the supplemental material). Overall, the mutant structures are similar to
those of the WT CA (root mean square deviation [RMSD], 0.394 Å for P122A and 0.400 Å
for I124A), indicating that the mutations did not disrupt the overall folding of the CA
protein. Rather, the mutations primarily resulted in local structural rearrangements at or
near the site of the mutations. Speciﬁcally, the P122A and I124A mutations resulted in
alterations in the PPIP motif itself and induced subtle repositioning of residues 92 to 96
in the CypA loop (Fig. 5A and B). Moreover, residue Q176 in the P122A mutant assumed
a conformation different from that seen with CA WT (Fig. 5C and D), while Q176
adopted the WT conformation in the P124A mutant, despite some ﬂexibility (Fig. 5E).
To characterize in more detail the ability of the PPIP mutants to assemble into a
mature CA lattice, we investigated their in vitro assembly properties. Under high-salt
conditions, WT CA monomers assemble into tubular structures composed of mature CA
FIG 5 X-ray crystallography demonstrated that P122A and I124A mutations subtly affect the PPIP motif,
CypA-binding loop, and CANTD-CACTD intraprotomer interface. (A and B) CA WT hexamers (CANTD in white,
CACTD in gray) with mutation sites (in spheres) are shown in cartoon form. Small boxes show closeup
views of changes induced by (A) P122A (in blue) and (B) I124A (in pink). The mutant proteins (shown as
a C tracing) are superposed with CA WT (in white). (C) The CA WT protomer (CANTD in white, CACTD in
gray) is shown in ribbon. Side chains of R143 and Q176 are shown as sticks. (D and E) Enlarged views of
the boxed region in panel C. P122A (in blue) (D) or I124A (in pink) (E) is shown superposed with the CA
WT. The red arrow in panel D highlights repositioning of Q176 in P122A mutant. CypA loop, CypA
binding loop.
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hexamers (35, 36). The efﬁciency of tube formation can be monitored either by direct
EM observation or by measuring the increase in optical density (turbidity) of the
reaction as the CA protein assembles in solution. We performed in vitro assembly
reactions with WT, P122A, and I124A CA proteins and examined the assembly products
by EM (Fig. 6). The results indicated that both the P122A and I124A CA proteins were
able to assemble into tubes in vitro. However, some differences in assembly efﬁciency
were observed; P122A CA protein assembled with kinetics that were even faster than
those of the WT, whereas I124A CA assembled more slowly than the WT and, unlike the
WT and P122A CA protein, did not assemble at concentrations of 6 mg/ml (data not
shown). Overall, these data suggest that the PPIP(122–125) loop is a structural element
critical for the formation of the immature Gag lattice but plays a less signiﬁcant role in
formation of the mature CA lattice.
Compensatory mutations obtained by in vitro selection rescue the replication
defects imposed by PPIP(122–125) mutations. To elucidate the interplay between
the PPIP loop and the remainder of CA during virus assembly and maturation, we
selected for viruses with compensatory mutations that rescue the defects imposed by
P122A and I124A. As a starting point, the highly permissive MT-4 T-cell line was
transfected with WT, P122A, and I124A pNL4-3 molecular clones, and virus replication
was monitored by RT assay. As shown in Fig. 3A, virus replication was markedly delayed
in the cultures transfected with the P122A and I124A mutants (Fig. 7A). Supernatants
were harvested from the peaks of virus replication, normalized for RT activity, and used
to reinfect fresh MT-4 cells. The repassaged virus, derived from multiple independent
ﬂasks, replicated with near-WT kinetics (Fig. 7B), demonstrating that the viruses had
reverted and/or acquired second-site compensatory mutations that rescued the defects
imposed by the original PPIP motif substitutions. The Gag coding region from 20
putative revertant viruses was sequenced, and a number of second-site mutations were
identiﬁed (Fig. 7C). In some cases, the I124A mutant reverted via a primary-site change
(I124V or I124T). To analyze the ability of the second-site mutations acquired during
passaging to rescue the defects conferred by the P122A and I124A substitutions, we
introduced these mutations into the P122A or I124A clones. All of the viruses contain-
ing second-site changes, except for the A105T/P122A mutant, were replication com-
petent in MT-4 cells (data not shown).
As mentioned above, the MT-4 T-cell line is highly permissive for HIV-1 replication.
To investigate further the ability of the selected second-site mutations to rescue P122A-
and I124A-imposed defects, we performed replication assays in the less permissive
Jurkat T-cell line. In contrast to the results obtained in MT-4 cells, we observed in the
Jurkat cells a wider range of replicative capacity for the mutants (Fig. 7D to E). Among
the P122A-containing viruses, three mutants—T107I/P122A, V36I/P122A, and A105T/
P122A—did not replicate during 2 months in culture in three independent experiments
(Fig. 7D and data not shown). All other mutants exhibited modest to marked delays in
replication, with RT levels peaking between 10 and 30 days. We collected several viral
samples at the RT peaks and repassaged them in Jurkat cells to identify additional
FIG 6 P122A and I124 CA mutants assemble into tubes in vitro. Wild-type and the two mutant CA
proteins were incubated in the presence of 1M NaCl, then stained and analyzed by EM. Tubular structures
were observed for WT CA protein (A) as well as for the P122A (B) and I124A (C) mutants. Scale bars,
100 nm.
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mutations (data not shown). Analysis of Gag sequences was performed for the viruses
that demonstrated improved replication kinetics relative to the ﬁrst passage. We found
that T58A/P122A acquired an additional change, V11I. We introduced V11I in the
context of P122A and T58A/P122A and observed that, while V11I alone was not able to
rescue the replication defects exhibited by P122A, the V11I/T58A/P122A triple mutant
displayed WT-like replication kinetics in three independent experiments (Fig. 7D and
data not shown). As the T58A mutation also rescued the replication capacity of I124A
in MT-4 cells (data not shown) and Jurkat cells (Fig. 7E), V11I was introduced in the
I124A molecular clone as well. In contrast to P122A mutant viruses, T58A signiﬁcantly
improved replication of the I124A mutant, with T58A/I124A showing a delay of only 4
FIG 7 P122A and I124A mutants acquire compensatory substitutions upon propagation in cell culture. (A) Multiple
ﬂasks of MT-4 cells were transfected with either P122A or I124A molecular clones (data from two ﬂasks are shown
for each mutant, indicated as “1” and “2”). Aliquots of the supernatants were collected every other day and
analyzed for RT activity. (B) Supernatants collected at the peak of the RT level analyzed as described for panel A
were used to infect fresh MT-4 cells. (C) At the RT peak in infected cultures, infected cells were pelleted, genomic
DNA was isolated, and gag regions of the proviral DNA were ampliﬁed by PCR. Sequencing of these PCR-ampliﬁed
fragments identiﬁed a set of second-site mutations in the CA-NTD. All revertant mutations were selected in MT-4
cells, except for V11I (*), which arose upon propagation of T58A/P122A in Jurkat cells. V11I was also engineered into
the T58A/I124A clone (**). (D, E) Jurkat cells were transfected with P122A-containing (D) or I124A-containing (E)
viral clones. Supernatants were collected every other day and analyzed for RT activity. Revertant viruses that were
selected for further analysis are indicated in boxes. (F) Location of the second-site mutations in the structure of the
mature CA monomer (PDB ID: 5MCX [27]).
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to 6 days relative to the WT (Fig. 7E). However, again, WT-like replication kinetics were
consistently observed only for the triple mutant, V11I/T58A/I124A (Fig. 7E). Similarly to
P122A-containing viruses, V11I alone was unable to compensate for the replication
defects conferred by I124A. All of the compensatory mutations identiﬁed in this analysis
were located in the CA-NTD and in most cases at residues distal to the PPIP motif
(Fig. 7F). Overall, experiments performed to select revertant viruses revealed that the
combination of two mutations, V11I and T58A, completely rescues the replication
defects imposed by both P122A and I124A in Jurkat cells and that a variety of other
mutations are able to confer partial rescue.
Compensatory mutations restore WT-like virus particle production, infectivity,
and virion morphology. To elucidate the mechanism by which the identiﬁed CA-NTD
mutations corrected the replication defects imposed by the P122A and I124A substi-
tutions, we focused on the four viral revertants—T58S/T107I/P122A, V11I/T58A/P122A,
T58A/I124A, and V11I/T58A/I124A—that exhibited the most improved replication ki-
netics in Jurkat cells (Fig. 7D and E). Virus particle production, Gag processing, virion
infectivity, and particle morphology were examined. For all of the mutants, the efﬁ-
ciency of virus assembly and release was restored to near-WT levels (Fig. 8A). Similarly,
the Gag processing defects observed with the original P122A and I124A mutants were
corrected in the revertants (Fig. 8B). Infectivity of the mutant viruses was also signiﬁ-
cantly improved (Fig. 8C). Virions with WT morphology were detected in all samples by
TEM (data not shown). Analyzing the T58S/T107I/P122A PR revertant particles further
by cryo-ET, we found that the compensatory mutations restored immature Gag lattice
formation and particle size distribution to WT-like levels (Fig. 4B, C, D, and E). Overall,
a combination of two mutations—V11I/T58A or T58S/T107I—was able to compensate
for the original defect caused by the P122A substitution, leading to production of
infectious virions (Fig. 8C); the former combination was also capable of rescuing the
replication competency of I124A.
DISCUSSION
Analysis of CA sequences across HIV-1 subtypes revealed the presence of a highly
conserved, Pro-rich motif in a short, exposed loop between helices 6 and 7 in the
CA-NTD. In the present study, we determined the role of this PPIP(122–125) motif in the
HIV-1 replication cycle by biochemical, virological, and structural approaches. We
demonstrated that substitutions in the PPIP motif result in severe defects in the
assembly of the immature Gag lattice and subsequent virion maturation, leading to
reduced production of infectious HIV-1 particles. Compensatory mutations within the
CA-NTD that rescue these defects were identiﬁed.
In the immature Gag lattice, the H6-H7 loop is located in close proximity to the same
loop from two neighboring hexamers (Fig. 1B). In contrast, in the mature hexameric
lattice, this region does not appear to be directly involved in forming CA-CA contacts
(Fig. 1C). The three Pro residues of the PPIP(122–125) motif are conserved in 95% of
HIV-1 isolates; Ile124 is found in 67% of the viral isolates in the HIV-1 database, while
Val is present at that position in 32% of the HIV-1 sequences (http://hivmut.org/) (37).
Among other primate lentiviruses (e.g., HIV-2 Gag-Pol [UniProt entry P04584], SIVmac
Gag-Pol [UniProt entry P05897], and SIVagm Gag-Pol [UniProt entry Q02836]), an Ile or
Val and at least one Pro are present, presumably forming a conserved structural
element in CA—a turn between two helices. Despite the highly conserved nature of the
HIV-1 PPIP(122–125) motif, a mutation of either P123 or P125 to Ala is relatively well
tolerated in terms of virus assembly, although P125A exhibits a severe infectivity defect.
In contrast, mutation of either P122 or I124 markedly impairs virus assembly; aberrant
Gag lattices are also observed at sites of P122A and I124A assembly at the PM of
virus-producing cells, indicating severe defects at early stages of assembly. The P122A
and I124A mutants both produce virions with a disordered Gag lattice and a wider size
distribution than the WT. Together, these data demonstrate that the PPIP(122–125)
loop plays a critical role in the assembly of an ordered, immature Gag lattice.
Although our data demonstrate that mutation of the PPIP(122–125) motif blocks the
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formation of an ordered, immature Gag lattice, EM analysis of P122A and I124A virions
revealed heterogeneous particles with diverse structural defects, i.e., particles with
patches of Gag-like lattices and condensed or dispersed viral material and a complete
absence of mature, conical cores. Several explanations could account for the failure of
these mutants to complete conical core formation. (i) Although X-ray crystallography
analysis did not reveal any major structural perturbations resulting from these muta-
tions, we did observe conformational changes in several regions of CA, including the
intraprotomer interface. In addition, EM analysis of in vitro CA assembly products
revealed that both mutant proteins are able to form tubular structures, albeit with
some differences in kinetics relative to the WT protein. (ii) P122A and I124A mutants
exhibit a defect in Gag processing which results in reduced levels of mature CA in
mutant virions relative to the WT. It is well established that incomplete Gag processing
impairs conical core formation. Complete capsid cores consist of approximately 1,500
FIG 8 Compensatory mutations reverse the P122A- and I124A-imposed defects in virus particle
production, Gag processing, and infectivity. (A and B) HeLa cells were transfected with the indicated
HIV-1 molecular clones. At 24 h posttransfection, cells were metabolically labeled with [35S]Met/Cys, and
released virus particles were collected by ultracentrifugation. Cell lysates were immunoprecipitated with
HIV-Ig. Cell-associated and virion-associated proteins were separated by SDS-PAGE and quantiﬁed by
phosphorimager analysis. Relative virus release efﬁciency was calculated as the ratio of virus-associated
CA to the total (cell plus virus) Gag, with the WT value set at 100; error bars indicate SD; n  3
independent experiments. Gag processing efﬁciency in cell lysates was calculated as CA/(CA Pr55Gag).
Error bars indicate SD; n  3 independent experiments. (C) TZM-bl cells were incubated with HeLa-
derived viral stocks in the presence of DEAE-dextran. After 2 to 3 h, the medium was replaced, and
luciferase activity was analyzed at 48 h postinfection. Luciferase signals were normalized based on levels
of virus-associated RT. Error bars indicate SD; n  3 independent experiments.
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copies of mature CA, and similar numbers of CA subunits remain unassembled in WT
virions (38). It is possible that the requisite number of CA subunits is not generated in
P122A or I124A particles. (iii) P122A and I124A mutant virions contain an elevated level
of the CA-SP1 processing intermediate relative to the WT virions. It has been demon-
strated that the presence of Gag processing intermediates, including CA-SP1, exerts a
dominant-negative effect on core condensation and that dysregulation of the sequen-
tial Gag processing pathway is detrimental to proper virion maturation (39–43). These
three models are not mutually exclusive; the combination of conformational changes in
CA, lower levels of mature CA, and higher levels of CA-SP1 in P122A and I124A virions
could act in concert to prevent conical core formation.
HIV-1 MIs are thought to block CA-SP1 processing by binding within a six-helix
bundle that forms at the CA-SP1 junction in the immature Gag lattice (22, 23). Despite
the severe defects in immature lattice assembly induced by the P122A and I124A
mutations, these CA-NTD substitutions do not prevent MIs from blocking CA-SP1
processing. This result implies that changes in the PPIP(122–125) motif do not prevent
the formation of the six-helix bundle at the CA-SP1 junction and thus do not abrogate
hexamer assembly. Interestingly, there does appear to be some cross talk between the
PPIP(122–125) motif and SP1, as a mutation at residue 8 of SP1 (SP1-T8I [44, 45]) results
in conformational changes in the PPIP(122–125) loop (46).
Sequential propagation of the P122A and I124A mutants in the MT-4 and Jurkat
T-cell lines led to the emergence of escape mutants containing second-site changes
within the CA-NTD. Most of the compensatory mutations were located at sites distal to
the original substitutions and were distributed throughout the CA-NTD. Among the
changes identiﬁed, only a combination of V11I and T58A mutations led to nearly
complete recovery of virus particle production, virion infectivity, and multicycle repli-
cation. V11 is located in the unfolded ﬂexible region that connects MA and CA in the
immature Gag lattice, and V11 is a part of the -hairpin that forms between Pro1 and
D51 of CA in mature CA (47). In both immature and mature structures, T58 is located
in the hydrophobic core formed by CA-NTD helices. V11I alone did not rescue the
replication ability of either P122A or I124A. T58A improved replication capacity only for
I124A virus, but the addition of V11I was required to fully rescue replication kinetics of
both T58A/P122A and T58A/I124A mutants. Interestingly, a previous study demon-
strated that T58I enhances CA-NC assembly in vitro (48).
In this study, we characterized the role of the PPIP(122–125) motif in the CA-NTD in
HIV-1 Gag assembly and particle maturation. Our functional data, consistent with recent
structural data on CA in the immature lattice (21), suggest that this exposed loop plays
a key role in the formation of the interhexameric contacts required for assembly of the
immature HIV-1 Gag lattice. Future studies will examine in more detail the mechanism
by which second-site changes within the CA-NTD, distal from the location of the
original mutations, are able to rescue particle assembly and infectivity.
MATERIALS AND METHODS
Cell lines. HeLa, 293T, and HeLa-derived TZM-bl cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum (FBS), 2 mM L-glutamine (Gibco),
100 U/ml penicillin, and 100 g/ml streptomycin, at 37°C and 5% CO2. The TZM-bl indicator cell line
expresses luciferase upon infection by HIV (49). MT-4 and Jurkat CD4 T-cell lines were cultured in RPMI
1640 medium, supplemented with 10% (vol/vol) FBS, 100 U/ml penicillin, 100 g/ml streptomycin, and
2 mM L-glutamine, at 37°C and 5% CO2.
Plasmids. Full-length proviral clone pNL4-3 (50) was used for production of HIV-1 particles. pNL4-3
clones bearing CA mutations were generated either by site-directed mutagenesis using a pGEM-based
subclone containing a nucleotide (nt) 588 to 2295 gag fragment or by direct ampliﬁcation of gag regions
bearing CA mutations from genomic DNA of infected cells followed by ligation of BssHII-ApaI or
BssHII-SpeI fragments into pNL4-3. For collection of immature HIV-1 WT and PPIP mutant particles,
molecular clones bearing the Asp25Asn mutation that inactivates PR were used (51). For expression and
puriﬁcation of CA proteins, P122A and I124A mutations were introduced into the pET11a HIV-1 CA
Escherichia coli expression plasmid kindly provided by C. Tang (52).
Virus release assay. HeLa cells were plated in a 12-well plate and transfected with viral clones using
Lipofectamine 2000 according to the manufacturer’s instructions. At 24 h posttransfection, the medium
was replaced with 0.5 ml of Met/Cys-free medium for 30 min and then metabolically labeled with a
[35S]Met/Cys-Pro mix (PerkinElmer). After incubation for 3 h, viral particles were collected by ﬁltering
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supernatants through 0.45-m-pore-size membrane ﬁlters and were pelleted by ultracentrifugation.
Virion-containing pellets were resuspended in lysis buffer. Cells were solubilized in 250 l of lysis buffer,
preheated with 15 l of 2  sample buffer (125 mM Tris-HCl [pH 6.8] containing 6% SDS, 10%
2-mercaptoethanol, and 20% glycerol) for 5 min at 95°C to disrupt Gag multimers and were immuno-
precipitated with anti-HIV-1 IgG, a pooled patient serum obtained from the NIH AIDS Reagent Program.
Cell and virus protein samples were separated on a 13% SDS-polyacrylamide gel, exposed to a
phosphorimager cassette, and quantiﬁed by the use of Quantity One software (Bio-Rad). Relative virus
release efﬁciency values were calculated as the amount of CA in virions divided by the sum of viral CA,
cellular Gag, and cellular CA; the numbers were subsequently normalized to WT sample values. For
calculation of standard deviations and standard errors of the means, at least three independent
experiments were performed.
Analysis of Gag processing products in virions. To analyze Pr55Gag levels, 293T cells were
transfected with the indicated viral clones using Lipofectamine 2000 (Invitrogen) following the manu-
facturer’s protocol. At 48 h posttransfection, 3.5 ml of the supernatants was ﬁltered through 0.45-m-
pore-size membrane ﬁlters, pelleted, and resuspended in lysis buffer (50 mM Tris-HCl [pH 7.5], 300 mM
NaCl, 0.5% Triton X-100, 10 mM iodoacetamide, and protease inhibitor cocktail tablets [Roche]). The
samples were subjected to 12% SDS-PAGE and then transferred to a polyvinylidene ﬂuoride (PVDF)
membrane (Immobilon, Millipore) by wet electroblotting. The membrane was blocked for 30 min with
5% nonfat milk–Tris-buffered saline–0.05% Tween 20 detergent and incubated overnight at 4°C with
anti-HIV-1 IgG. The membrane was washed, incubated for 45 min with anti-human horseradish
peroxidase-conjugated secondary antibody, and washed again. Supersignal West Pico reagent (Thermo
Scientiﬁc) was used to reveal protein bands followed by analysis performed with ImageLab software
(Bio-Rad). To analyze CA-SP1 levels in virions produced in the absence or presence of MIs, CA-SP1
accumulation assays were performed with [35S]Met/Cys-containing media as described previously using
293T cells as virus producer cells (34, 53). To obtain a clear separation between CA and CA-SP1, samples
were resolved on a 15% SDS-polyacrylamide gel. The effect of BVM, 7m, or 7r was tested at 100 nM.
Virus replication kinetics. For transfection, 2.5 106 MT-4 cells and Jurkat cells were mixed with
1 g and 2.5 g plasmid DNA, respectively, in 500 l of 0.8 mg/ml DEAE-dextran solution. After 15 min
of incubation at 37°C, cells were washed with 4 ml of 1 STBS (25 mM Tris-HCl [pH 7.4], 0.6 mM Na2HPO4,
5 mM KCl, 140 mM NaCl, 0.7 mM CaCl2, 0.5 mM MgCl2) and pelleted by centrifugation. The cell pellets
were resuspended in 2.5 ml RPMI medium and transferred to tissue culture ﬂasks. Aliquots of superna-
tants were collected to monitor RT activity, and cells were split every other day. For reinfection, 1.5 106
MT-4 cells or 2.5 106 Jurkat cells were mixed with RT-normalized viral stocks, incubated for 2 h at 37°C,
and pelleted by centrifugation. Cell pellets were resuspended in 2.5 ml RPMI medium and transferred to
tissue culture ﬂasks. On the days of peak RT activity, the genomic DNA was extracted using a QIAamp
genomic DNA extraction kit (Qiagen), and CA-coding regions were ampliﬁed and sequenced (Macrogen).
Single-cycle infectivity assay. TZM-bl cells (2 104) were plated into each well of a 96-well plate.
After 24 h, serial dilutions of viral stocks collected from HeLa cells were added to the cells in the presence
of 10 g/ml DEAE-dextran, and the medium was changed after incubation for 2 h to 4 h. At 48 h
postinfection, the culture medium was removed and infected cells were washed once in 1 PBS and
lysed in 30 l of britelite plus reagent (Perkin-Elmer). Detected luminescent signals were normalized to
the RT activity of viral samples measured as described previously (54). WT values were set at 100%. At
least three independent experiments were performed.
Cryo-ET. WT and I124A virions and PR derivatives of WT, P122A, I124A, and T58S/T107I/P122A
virions were imaged by cryo-ET as described previously (55). Brieﬂy, puriﬁed ﬁxed virus was mixed (2:1)
with a suspension of colloidal gold particles (Electron Microscopy Sciences), applied to Quantifoil R2/2
200 mesh holey carbon grids (Structure Probe, Inc.), and plunge-frozen in ethane using a Leica EM GP
(Leica Microsystems). For data acquisition, grids were transferred to a cryo-holder (type 626 or 914;
Gatan), and single-axis tilt series were recorded at 120 keV on a Tecnai-12 electron microscope through
a zero-loss energy ﬁlter (GIF 2002; Gatan) with a slit width of 20 eV. Images were acquired on a
2,048-by-2,048-pixel charge-coupled-device (CCD) camera (Gatan) using SerialEM (56). Tilt-series projec-
tions were typically acquired at 1.5° or 2° increments from 60° to 60° and at 38,500 magniﬁcation
(7.8 Å/pixel) and 3.5-m defocus. The electron dose per projection was 1.2 e/Å2, giving a total
cumulative dose of 75 e/Å2. Tilt series were reconstructed using the Bsoft package (57), and virions
were extracted and denoised by 20 iterations of anisotropic nonlinear diffusion (58).
Morphological analysis. Size and Gag layer coverage were evaluated for each PR particle in the
cryo-ET data set. The central section was located for each particle. The diameter was determined at the
longest axis of each central section using the “measure” tool in Bshow. To assess Gag layer coverage for
a given particle, the angular measure for each visible Gag layer arc in the central slice was determined
manually. The angular measures of all Gag layer arcs were summed, and this sum was divided by 360°
to yield the overall Gag layer coverage for that particle.
Subtomogram averaging. Subtomogram averaging was performed as previously described (45).
Brieﬂy, subtomograms containing patches of the Gag layer were manually selected in the denoised
tomograms and extracted from the corresponding raw tomograms. Initial orientations of the
subtomograms were deﬁned by vectors from the virion centers directed radially outward. The
average of all selected subtomograms was used as an initial reference for alignment. Subtomogram
alignment, taking into account the missing wedge of information, was performed using routines
from Bsoft (57) wrapped into Python scripts. Initial alignment steps involved 2 iterations of only
translational alignment. As a result of this process, subtomograms were not rotationally aligned, and
therefore the Gag-related lattices were not in register. For the next steps, the viral membrane and
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MA layers were masked off. One subtomogram was selected, C6 symmetry was applied, and this
subtomogram was used as a reference for a full rotational and translational alignment. This
alignment procedure was iterated ﬁve times, using as a reference the average of the top 50% of the
particles (as ranked by correlation coefﬁcients) from the previous iteration. Classiﬁcation and
averaging procedures were then performed by maximum likelihood analysis as implemented in the
Xmipp package (59). Approximately, the top 75% of the initially selected subtomograms were used
to calculate the ﬁnal averages.
Crystallization of CA mutants, data collection, and structure determination. P122A and I124A CA
were cloned without fusion tags in the pET11a plasmid. Mutant proteins were expressed and puriﬁed as
previously described (26). Crystals of the P122A and I124A CA grew at 18°C in hanging drops containing
5 mg/ml of protein, 6% to 9% polyethylene glycol (PEG) 3350, 2% to 6% glycerol, sodium iodide, and
sodium cacodylate. Hexagonal plate-like crystals appeared after 5 days, and crystal growth was com-
pleted over 2 weeks. Crystals were brieﬂy soaked in 20% glycerol or parafﬁn oil before they were
subjected to cryo-cooling in liquid nitrogen. Data were collected on a complementary metal-oxide
semiconductor (CMOS) detector at Advanced Light Source (ALS) beamline 4.2.2 (Lawrence Berkeley
National Laboratory) or a Dectris Eiger-16M detector at Advanced Photon Source (APS) beamline 23 ID-B
(Argonne National Laboratory). Datasets were collected and processed using XDS (60). The data were
examined for the presence of systematic absences; however, no characteristic patterns were observed.
Thus, the crystals were indexed in hexagonal space group P6 with one CA molecule in the asymmetric
unit. No twinning was present, as determined by either POINTLESS (61) or XTRIAGE (62). Space group and
twinning data were also veriﬁed in ZANUDA (63). The CA phase problem was solved using molecular
replacement, with the native CA (PDB identiﬁer [ID]: 4XFX) as a starting model. Initial phases were solved
via the use of PHASER (63). Several rounds of iterative model building and reﬁnement were carried out
using Coot (64) and PHENIX (62), REFMAC (65), or PDBREDO (http://www.cmbi.ru.nl/pdb_redo/). Struc-
ture validation of ﬁnal models was performed with MOLPROBITY (http://molprobity.biochem.duke.edu/).
Accessible and buried surface area data were calculated using PISA (http://www.ccp4.ac.uk/pisa/). The
ﬁgures showing structural information were generated in PyMOL (http://www.pymol.org/).
In vitro assembly of HIV-1 CA proteins. In vitro assembly reactions were performed by using
methods developed in other studies (35, 47, 66) with some modiﬁcations. Brieﬂy, CA protein, puriﬁed as
described previously (26), was incubated at a concentration of 6 mg/ml in 50 mM Tris-HCl (pH 7.5 to
8)–1 M NaCl for 15 to 30 min at room temperature and then overnight at 4°C. For negatively stained EM
images, aliqouts of in vitro assembly reactions were placed on Formvar carbon-coated grids, incubated
for 30 s, and then rinsed with water three times and stained with 2% uranyl formate for 30 s. Excess
material was removed from the grids with Whatman ﬁlter paper. The images were collected using a
Hitachi 7600 transmission electron microscope.
Structural modeling. Models of the CA monomer, immature Gag lattice, and mature core were
generated using PyMOL software.
Accession numbers. P122A, PDB ID 6AXR; I124A, PDB ID 6AXW.
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